Laboratory Services Agreement Sample Contracts

Share Cite Term
Link

Embed (HTML)
MultiVir Inc. – Saint Louis University Laboratory Services Agreement (March 30th, 2015)

THIS LABORATORY SERVICES AGREEMENT (Agreement) is made effective as of December 3, 2012 (Effective Date) by and between VirRx, Inc., having a principal place of business at 1609 Adgers Wharf Drive (Company) and Saint Louis University, a Missouri benevolent corporation having its principal place of business located at 221 North Grand Boulevard, St. Louis, Missouri 63103 (SLU or Laboratory). Company and Laboratory are sometimes referred to herein individually as a Party and collectively as the Parties.

Signal Genetics, Inc. – Reference Laboratory Services Agreement (December 23rd, 2014)

This Reference Laboratory Services Agreement (the "Agreement") made this September 20, 2014, by and between The Board of Trustees of the University of Arkansas acting for and on behalf of the UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES (hereinafter called "UAMS") and SIGNAL GENETICS, INC., a Delaware corporation, (hereinafter called "LABORATORY") with reference to the following facts:

Signal Genetics, Inc. – Reference Laboratory Services Agreement for Research Specimins (December 23rd, 2014)

This Reference Laboratory Services Agreement (the "Agreement") made this September 20, 2014, by and between The Board of Trustees of the University of Arkansas acting for and on behalf of the UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES (hereinafter called "UAMS") and SIGNAL GENETICS, INC., a Delaware corporation (hereinafter called "LABORATORY") with reference to the following facts:

MultiVir Inc. – Saint Louis University Laboratory Services Agreement (December 22nd, 2014)

THIS LABORATORY SERVICES AGREEMENT (Agreement) is made effective as of December 3, 2012 (Effective Date) by and between VirRx, Inc., having a principal place of business at 1609 Adgers Wharf Drive (Company) and Saint Louis University, a Missouri benevolent corporation having its principal place of business located at 221 North Grand Boulevard, St. Louis, Missouri 63103 (SLU or Laboratory). Company and Laboratory are sometimes referred to herein individually as a Party and collectively as the Parties.

Signal Genetics, Inc. – Reference Laboratory Services Agreement (November 14th, 2014)

This Reference Laboratory Services Agreement (the "Agreement") made this September 20, 2014, by and between The Board of Trustees of the University of Arkansas acting for and on behalf of the UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES (hereinafter called "UAMS") and SIGNAL GENETICS, INC., a Delaware corporation, (hereinafter called "LABORATORY") with reference to the following facts:

Signal Genetics, Inc. – Reference Laboratory Services Agreement for Research Specimins (November 14th, 2014)

This Reference Laboratory Services Agreement (the "Agreement") made this September 20, 2014, by and between The Board of Trustees of the University of Arkansas acting for and on behalf of the UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES (hereinafter called "UAMS") and SIGNAL GENETICS, INC., a Delaware corporation (hereinafter called "LABORATORY") with reference to the following facts:

Prana Biotechnology Ltd – Master Laboratory Services Agreement (November 3rd, 2014)

THIS AMENDMENT ("Amendment") is made as of 19th day of November, 2013 (the "Effective Date") by and between Prana Biotechnology, Ltd., ACN 080 699 065, an Australian limited liability company whose address is Level 2, 369 Royal Parade, Parkville Victoria 3052 ("Sponsor") and WIL Research Laboratories LLC (together with its subsidiaries), a Delaware limited liability company, with a principal place of business at 1407 George Road, Ashland, OH 44805 (hereinafter collectively referred to as "WIL").

AMENDMENT to the ELI LILLY AND COMPANY & CELLULAR DYNAMICS INTERNATIONAL INC Master Laboratory Services Agreement (June 4th, 2014)

WHEREAS, Eli Lilly and Company (Lilly) and Cellular Dynamics International Inc (CDI) desire to amend the Master Laboratory Services Agreement effective November 22, 2010 (the "Agreement")

Signal Genetics, Inc. – Reference Laboratory Services Agreement for Research Specimens (March 19th, 2014)

This Reference Laboratory Services Agreement (the "Agreement") made this March 21, 2011, by and between The Board of Trustees of the University of Arkansas acting for and on behalf of the UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES' Myleoma Institute for Research Therapy (MIRT) (hereinafter called "UAMS") and SIGNAL GENETICS LLC, a Delaware limited liability company (hereinafter called "LABORATORY") with reference to the following facts:

Signal Genetics, Inc. – Reference Laboratory Services Agreement (March 19th, 2014)

This Reference Laboratory Services Agreement (the "Agreement") made this March 21, 2011, by and between The Board of Trustees of the University of Arkansas acting for and on behalf of the UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES' Clinical Laboratory (hereinafter called "UAMS") and SIGNAL GENETICS LLC, a Delaware limited liability company, (hereinafter called "LABORATORY") with reference to the following facts:

Dipexium Pharmaceuticals, Inc. – Laboratory Services Agreement (February 6th, 2014)

The terms stated herein are agreed to be those which will apply to studies performed by Dipexium Pharmaceuticals (Sponsor) by Covance Laboratories Inc. and Covance Bioanalytical Services LLC (collectively referred to as Covance):

Kindred Biosciences, Inc. – Non-Glp Laboratory Services Agreement (November 8th, 2013)

This Agreement ("Agreement") is made as of July 22, 2013 (the "Effective Date") by and between the IDEXX BioResearch Division of IDEXX Reference Laboratories, Inc., a Delaware corporation with an office located at One IDEXX Drive, Westbrook, ME 04092 ("IDEXX"), and Kindred Biosciences, Inc., a Delaware corporation having its principal place of business at 1499 Bayshore Highway #226, San Francisco, CA 94010 ("Client").

Kindred Biosciences, Inc. – Non-Glp Laboratory Services Agreement (October 2nd, 2013)

This Agreement ("Agreement") is made as of July 22, 2013 (the "Effective Date") by and between the IDEXX BioResearch Division of IDEXX Reference Laboratories, Inc., a Delaware corporation with an office located at One IDEXX Drive, Westbrook, ME 04092 ("IDEXX"), and Kindred Biosciences, Inc., a Delaware corporation having its principal place of business at 1499 Bayshore Highway #226, San Francisco, CA 94010 ("Client").

Laboratory Services Agreement (September 23rd, 2013)

This LABORATORY SERVICES AGREEMENT (hereinafter referred to as the Agreement is made by and between Biocept, Inc. (Biocept), a California Corporation having its principal place of business at 5810 Nancy Ridge Drive, Suite 150, San Diego, CA 92121, and Clarient Diagnostic Services, Inc., a wholly owned subsidiary of Clarient, Inc., a Delaware corporation, having its principal place of business at 31 Columbia, Aliso Viejo, CA, 92656 (hereinafter referred to as the Clarient). This Agreement replaces, as of the Effective Date, any former agreements or letters of intent that were previously signed by both parties, including that certain Collaboration Agreement, as amended, by and between Biocept and Clarient dated as of August 17, 2011, which is hereby terminated as of the Effective Date, but excluding the letter agreement between the parties dated December 5, 2012 regarding SOW#01 and the DFPCC Agreement, which shall continue.

Laboratory Services Agreement (August 19th, 2013)

This LABORATORY SERVICES AGREEMENT (hereinafter referred to as the Agreement is made by and between Biocept, Inc. (Biocept), a California Corporation having its principal place of business at 5810 Nancy Ridge Drive, Suite 150, San Diego, CA 92121, and Clarient Diagnostic Services, Inc., a wholly owned subsidiary of Clarient, Inc., a Delaware corporation, having its principal place of business at 31 Columbia, Aliso Viejo, CA, 92656 (hereinafter referred to as the Clarient). This Agreement replaces, as of the Effective Date, any former agreements or letters of intent that were previously signed by both parties, including that certain Collaboration Agreement, as amended, by and between Biocept and Clarient dated as of August 17, 2011, which is hereby terminated as of the Effective Date, but excluding the letter agreement between the parties dated December 5, 2012 regarding SOW#01 and the DFPCC Agreement, which shall continue.

Master Laboratory Services Agreement (June 3rd, 2013)

This is an agreement between Eli Lilly and Company, an Indiana corporation ("Lilly") and Cellular Dynamics International Inc., having its principal place of business at University Research Park, 525 Science Drive, Suite 200, Madison, WI 53711 ("CDI").

Master Laboratory Services Agreement (April 10th, 2013)

This is an agreement between Eli Lilly and Company, an Indiana corporation ("Lilly") and Cellular Dynamics International Inc., having its principal place of business at University Research Park, 525 Science Drive, Suite 200, Madison, WI 53711 ("CDI").

AMENDMENT #1 to the MASTER LABORATORY SERVICES AGREEMENT (September 4th, 2012)

THIS AMENDMENT ("Amendment") is made as of October 28, 2011 (the "Effective Date") by and between INTERCEPT PHARMACEUTALS, INC., whose address is 18 Desbrosses Street, New York, NY 10013 ("Sponsor") and WIL RESEARCH LABORATORIES LLC, a Delaware limited liability company, with a principal place of business at 1407 George Road, Ashland, OH 44805 ("WIL").

ShangPharma Corp – Master Laboratory Services Agreement (October 7th, 2010)
ShangPharma Corp – Master Laboratory Services Agreement (October 7th, 2010)
Laboratory Services Agreement (June 30th, 2009)

This Laboratory Services Agreement ("Agreement") is made and entered into effective as of April 10, 2009, (the "Effective Date") by and between Rosetta Genomics Inc., a corporation organized under the laws of Delaware, having a principal place of business at 3711 Market St., Suite 740, Philadelphia, PA, 19104 ("Rosetta"), and Prometheus Laboratories Inc., a California corporation, having its principal place of business at 9410 Carroll Park Drive, San Diego, CA 92121 USA ("Prometheus"). Rosetta and Prometheus each may be referred to herein as a "Party" or collectively as the "Parties".

Sirion Holdings, Inc. – Master Laboratory Services Agreement (September 18th, 2006)

This Master Laboratory Services Agreement (Agreement), when signed by both parties, will set forth the terms and conditions between Rx DEVELOPMENT RESOURCES, a Florida corporation with its principal offices located at 3104 Cherry Palm Drive, Suite 260, Tampa, Florida 33619 (Sponsor) and QUINTILES LABORATORIES LIMITED, a North Carolina corporation with its principal offices located at 5500 Highlands Parkway, Suite 600, Smyrna, Georgia 30082 (QLAB), under which QLAB agrees to provide laboratory services to Sponsor as set forth below.

Sentigen Holding Corp – LABORATORY SERVICES AGREEMENT Dated as of April 1, 2006 by and Between MERCK & CO., INC. And CELL & MOLECULAR TECHNOLOGIES, INC. (May 15th, 2006)

This Laboratory Services AGREEMENT (this AGREEMENT), dated as of April 1, 2006, (the EFFECTIVE DATE) by and between Merck & Co., Inc., a New Jersey corporation (MERCK), with offices at One Merck Drive, Whitehouse Station, NJ 08889-0100 and Cell & Molecular Technologies, Inc. (SUPPLIER), with offices at 445 Marshall Street, Phillipsburg, New Jersey 08865.

Laboratory Services Agreement (November 28th, 2003)

This Laboratory Services Agreement (Agreement) effective as of April 1, 2003 (the Effective Date) is between Acorda Therapeutics, Inc. with an address at 15 Skyline Drive, Hawthorne, New York 10532, USA (Acorda) and Cardinal Health PTS, Inc. with an address of 160 Magellan Labs Ct., Morrisville, North Carolina, USA (Cardinal Health).

Laboratory Services Agreement (September 29th, 2003)

This Laboratory Services Agreement (Agreement) effective as of April 1, 2003 (the Effective Date) is between Acorda Therapeutics, Inc. with an address at 15 Skyline Drive, Hawthorne, New York 10532, USA (Acorda) and Cardinal Health PTS, Inc. with an address of 160 Magellan Labs Ct., Morrisville, North Carolina, USA (Cardinal Health).